CA Irvine의 다발성 골수종 임상 시험
다발성 골수종 관련 연구 14개가 Irvine 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
피험자 모집 중3상
- City of Hope - Lennar Foundation Cancer Center, Irvine
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
피험자 모집 중2상
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
피험자 모집 중3상
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
피험자 모집 중1상
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
피험자 모집 중3상
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
피험자 모집 중1/2상
- Research Site, Irvine
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
피험자 모집 중1/2상
- City of Hope Irvine Lennar, Irvine
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
피험자 모집 중2상
- City of Hope at Irvine Lennar, Irvine
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
피험자 모집 중1상
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 279067, Irvine
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
피험자 모집 중1/2상
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 277911, Irvine
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
피험자 모집 중3상
- UC Irvine Health Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
피험자 모집 중1/2상
- City of Hope - Lennar, Irvine
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
피험자 모집 중4상
- UCI Health - Irvine Infusion Pharmacy ACC, Irvine
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
피험자 모집 중관찰 연구건강한 지원자 환영
- City of Hope at Irvine Lennar, Irvine
다른 도시의 다발성 골수종 시험
- New York City, NY연구 59개
- Boston, MA연구 45개
- Atlanta, GA연구 42개
- Houston, TX연구 39개
- Durham, NC연구 36개
- Nashville, TN연구 31개
- Denver, CO연구 26개
- St. Louis, MO연구 26개
- Rochester, MN연구 25개
- Columbus, OH연구 25개
- Chicago, IL연구 24개
- Milwaukee, WI연구 23개
Irvine의 다른 연구
- 비소세포폐암연구 30개
- 유방암연구 23개
- 암 (전체)연구 18개
- 전이성 암연구 16개
- 폐암연구 15개
- 난소암연구 14개
- 전립선암연구 14개
- 알츠하이머병연구 12개
- 두경부 편평세포암연구 11개
- 방광암연구 11개
- 대장직장암연구 11개
- 자궁내막암연구 10개
ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.